Tue, 07 Oct 2008 14:41:51 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.3 - http://www.lemonzdream.com/podcastmaker PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2007 PeerView Press,24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/psychiatryvideo/PA03681FC_album_art_QAapp_200407_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Psychiatry no PeerView Press In this case-based CME activity, an expert on the diagnosis and management of bipolar disorder, schizophrenia, and schizoaffective disorder reviews the application of evidence-based best practices to real-world examples of these disorders. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this case-based CME activity, an expert on the diagnosis and management of bipolar disorder, schizophrenia, and schizoaffective disorder reviews the application of evidence-based best practices to real-world examples of these disorders. http://podcast.peerviewpress.com/psychiatryvideo/PA05020FCp149.m4v http://podcast.peerviewpress.com/psychiatryvideo/PA05020FCp149.m4v Tue, 30 Sep 2008 14:35:02 -0400 Science no 00:21:28 Psychosis, bipolar disorder, mania, depression, schizoaffective disorder, delusions, hallucinations, lithium, valproate, lamotrigine, carbemezepine ER, agitation PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatryvideo/PA05020FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatryvideo/PA05020FCCMEinfo.pdf Tue, 30 Sep 2008 14:34:49 -0400 Science no 00:00:00 Psychosis, bipolar disorder, mania, depression, schizoaffective disorder, delusions, hallucinations, lithium, valproate, lamotrigine, carbemezepine ER, agitation PeerView Press In this CME/CE activity, experts in the treatment of insomnia present recent data on the management of insomnia, including implications for older adults. New data on insomnia in women is also highlighted. In this CME/CE activity, experts in the treatment of insomnia present recent data on the management of insomnia, including implications for older adults. New data on insomnia in women is also highlighted. In this CME/CE activity, experts in the treatment of insomnia present recent data on the management of insomnia, including implications for older adults. New data on insomnia in women is also highlighted. http://podcast.peerviewpress.com/psychiatryvideo/PA04505FCs477.m4v http://podcast.peerviewpress.com/PsychiatryVideo/PA04505FCs477.m4v Thu, 31 Jul 2008 12:00:00 -0400 Science no 00:25:21 Insomnia, rebound insomnia, anxiety, depression, ramelteon, zolpidem, doxepin, cognitive-behavioral therapy, prescription drugs PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/psychiatry/PA04505FCs477CMEinfo.pdf http://podcast.peerviewpress.com/PsychiatryVideo/PA04505FCs477CMECEinfo.pdf Thu, 31 Jul 2008 12:00:00 -0400 Science no 00:00:00 Insomnia, rebound insomnia, anxiety, depression, ramelteon, zolpidem, doxepin, cognitive-behavioral therapy, prescription drugs PeerView Press Schizophrenia is rare in childhood, but its prevalence steadily increases during adolescence. Many of the symptoms associated with schizophrenia are relatively common and nonspecific; the differential diagnosis of schizophrenia is broad. The use of atypical antipsychotics has shown positive results in adults with schizophrenia. Relatively few data are available on the effectiveness of these agents in children and adolescents. However, a number of recent studies have shown some promising results and have added to this small body of evidence. Please be sure to view the accompanying (PDF) file for full CME/CE information. Schizophrenia is rare in childhood, but its prevalence steadily increases during adolescence. Many of the symptoms associated with schizophrenia are relatively common and nonspecific; the differential diagnosis of schizophrenia is broad. The use of atypical antipsychotics has shown positive results in adults with schizophrenia. Relatively few data are available on the effectiveness of these agents in children and adolescents. However, a number of recent studies have shown some promising results and have added to this small body of evidence. http://podcast.peerviewpress.com/PsychiatryVideo/PA04389FCp139.m4v http://podcast.peerviewpress.com/psychiatryvideo/PA04389FCp139.m4v Fri, 18 Apr 2008 10:17:41 -0400 Science no 00:24:20 Children, adolescents, risperidone, schizophrenia, aripiprazole, clozapine, atypicals, weight gain, hyperprolactinemia, quetiapine, olanzapine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA04389FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatryvideo/PA04389FCCMEinfo.pdf Fri, 18 Apr 2008 10:16:42 -0400 Science no 00:00:00 Children, adolescents, risperidone, schizophrenia, aripiprazole, clozapine, atypicals, weight gain, hyperprolactinemia, quetiapine, olanzapine PeerView Press In this CME activity, experts in fibromyalgia discuss its diagnosis and management. Current theories on the mechanisms of fibromyalgia are highlighted. Strategies for collaboration between multiple specialties in the treatment of patients with fibromyalgia are also featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in fibromyalgia discuss its diagnosis and management. Current theories on the mechanisms of fibromyalgia are highlighted. Strategies for collaboration between multiple specialties in the treatment of patients with fibromyalgia are also featured. http://podcast.peerviewpress.com/PsychiatryVideo/PA04160FCe009.m4v http://podcast.peerviewpress.com/psychiatryvideo/PA04160FCe009.m4v Thu, 31 Jan 2008 12:18:28 -0500 Science no 00:57:13 Fibromyalgia, FMS, Myofascial pain syndrome, Chronic fatigue syndrome, Hypothyroidism, Depression, Posttraumatic stress disorder, ACR criteria, Genetic factors, Central sensitization, Pregabalin, Duloxetine, Milnacipran, Tricyclic antidepressants PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA04160FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatryvideo/PA04160FCCMEinfo.pdf Thu, 31 Jan 2008 12:17:28 -0500 Science no 00:00:00 Fibromyalgia, FMS, Myofascial pain syndrome, Chronic fatigue syndrome, Hypothyroidism, Depression, Posttraumatic stress disorder, ACR criteria, Genetic factors, Central sensitization, Pregabalin, Duloxetine, Milnacipran, Tricyclic antidepressants PeerView Press In this educational activity, psychiatric experts discuss the prevalence, clinical presentation, and prognosis of early-onset schizophrenia. In addition, management issues, including the efficacy and safety of antipsychotic therapies and the integration of support therapies, are presented. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this educational activity, psychiatric experts discuss the prevalence, clinical presentation, and prognosis of early-onset schizophrenia. In addition, management issues, including the efficacy and safety of antipsychotic therapies and the integration of support therapies, are presented. http://podcast.peerviewpress.com/PsychiatryVideo/PA03919FCr337.m4v http://podcast.peerviewpress.com/psychiatryvideo/PA03919FCr337.m4v Wed, 24 Oct 2007 10:47:04 -0400 Science no 00:45:23 American Academy of Child and Adolescent Psychiatry (AACAP), Antipsychotic, atypical, Aripiprazole, Clozapine, Haloperidol, Olanzapine, Quetiapine, Risperidone, Schizophrenia, early-onset PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA03919FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatryvideo/PA03919FCCMEinfo.pdf Wed, 24 Oct 2007 10:47:02 -0400 Science no 00:00:00 American Academy of Child and Adolescent Psychiatry (AACAP), Antipsychotic, atypical, Aripiprazole, Clozapine, Haloperidol, Olanzapine, Quetiapine, Risperidone, Schizophrenia, early-onset PeerView Press In this activity, two expert psychiatrists and an endocrinologist discuss the prevalence and recognition of hyperprolactinemia in patients receiving antipsychotic medications and management strategies for reducing this risk. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, two expert psychiatrists and an endocrinologist discuss the prevalence and recognition of hyperprolactinemia in patients receiving antipsychotic medications and management strategies for reducing this risk. http://podcast.peerviewpress.com/PsychiatryVideo/PA03920FCe005.m4v http://podcast.peerviewpress.com/psychiatryvideo/PA03920FCe005.m4v Tue, 23 Oct 2007 15:44:12 -0400 Science no 01:03:19 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Psychiatry PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA03920FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatryvideo/PA03920FCCMEinfo.pdf Tue, 23 Oct 2007 15:44:05 -0400 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Psychiatry PeerView Press In this activity, psychiatric experts discuss best practices for the management of acute agitation in the emergency setting, which are likely to promote the success of longer-term care. Specifically, the goal of medically calming the acutely agitated patient, without inducing sedation, is advanced to foster voluntary care in the short term and to increase the probability of long-term treatment adherence. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, psychiatric experts discuss best practices for the management of acute agitation in the emergency setting, which are likely to promote the success of longer-term care. Specifically, the goal of medically calming the acutely agitated patient, without inducing sedation, is advanced to foster voluntary care in the short term and to increase the probability of long-term treatment adherence. http://podcast.peerviewpress.com/PsychiatryVideo/PA03846FCr312.m4v http://podcast.peerviewpress.com/psychiatryvideo/PA03846FCr312.m4v Tue, 14 Aug 2007 10:01:06 -0400 Science no 00:40:34 Agitation, acute, Antipsychotics, atypical, Antipsychotics, first-generation, Antipsychotics, second-generation, Antipsychotics, typical, Aripiprazole, Behavioral emergencies, Benzodiazepine, Bipolar disorder, Bipolar episode, Clozapine PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA03846FCCMEinfo.pdf http://podcast.peerviewpress.com/psychiatryvideo/PA03846FCCMEinfo.pdf Tue, 14 Aug 2007 10:01:04 -0400 Science no 00:00:00 Agitation, acute, Antipsychotics, atypical, Antipsychotics, first-generation, Antipsychotics, second-generation, Antipsychotics, typical, Aripiprazole, Behavioral emergencies, Benzodiazepine, Bipolar disorder, Bipolar episode, Clozapine PeerView Press In this activity, expert physicians discuss how to apply efficacy and safety data derived from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) to the long-term clinical management of schizophrenia. In addition, evidence-based support for the use of psychiatric agents as maintenance therapy in bipolar I disorder is presented. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, expert physicians discuss how to apply efficacy and safety data derived from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) to the long-term clinical management of schizophrenia. In addition, evidence-based support for the use of psychiatric agents as maintenance therapy in bipolar I disorder is presented. http://podcast.peerviewpress.com/PsychiatryVideo/PA03789FCe003.m4v http://podcast.peerviewpress.com/PsychiatryVideo/PA03789FCe003.m4v Thu, 17 May 2007 15:41:59 -0400 Science no 00:42:30 Aripiprazole, clozapine, olanzapine, risperidone, quetiapine, ziprasidone, lithium, lamotrigine, divalproex, perphenazine, schizophrenia, bipolar, bipolar disorder, CATIE, Clinical Antipsychotic Trials of Intervention Effectiveness PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA03789FCCMEinfo.pdf http://podcast.peerviewpress.com/PsychiatryVideo/PA03789FCCMEinfo.pdf Thu, 17 May 2007 15:41:41 -0400 Science no 00:00:00 Aripiprazole, clozapine, olanzapine, risperidone, quetiapine, ziprasidone, lithium, lamotrigine, divalproex, perphenazine, schizophrenia, bipolar, bipolar disorder, CATIE, Clinical Antipsychotic Trials of Intervention Effectiveness PeerView Press In this CME/CE activity, experts in the treatment of psychiatric disorders present recent data on the efficacy and safety of the use of atypical antipsychotics in the elderly. Dosing and management issues in this population are also highlighted. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME/CE activity, experts in the treatment of psychiatric disorders present recent data on the efficacy and safety of the use of atypical antipsychotics in the elderly. Dosing and management issues in this population are also highlighted. http://podcast.peerviewpress.com/PsychiatryVideo/PA03599FCr276.m4v http://podcast.peerviewpress.com/PsychiatryVideo/PA03599FCr276.m4v Thu, 10 May 2007 11:17:15 -0400 Science & Medicine no 00:36:29 Primary psychotic disorder, chronic or late-onset schizophrenia, late-onset delusional disorders, affective disorders, psychosis from neurodegenerative disorders, Alzheimer's disease, vascular dementia, Lewy body dementia, Parkinson's disease PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA03599FCCMEinfo.pdf http://podcast.peerviewpress.com/PsychiatryVideo/PA03599FCCMEinfo.pdf Thu, 10 May 2007 11:16:47 -0400 Science & Medicine no 00:00:00 Primary psychotic disorder, chronic or late-onset schizophrenia, late-onset delusional disorders, affective disorders, psychosis from neurodegenerative disorders, Alzheimer's disease, vascular dementia, Lewy body dementia, Parkinson's disease PeerView Press In this activity, experts discuss issues of dosing and switching atypical antipsychotics in patients with mental illness. Management strategies for weight gain, sedation, and other metabolic effects are featured. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts discuss issues of dosing and switching atypical antipsychotics in patients with mental illness. Management strategies for weight gain, sedation, and other metabolic effects are featured. http://podcast.peerviewpress.com/PsychiatryVideo/PA03288FCe001.m4v http://podcast.peerviewpress.com/psychiatryvideo/PA03288FCe001.m4v Fri, 04 May 2007 16:42:03 -0400 Science no 00:53:09 Bipolar disorder, schizophrenia, aripiprazole, clozapine, olanzapine, quetiapine, risperidone, ziprasidone, weight gain, sedation, atypical antipsychotic, side effects, dosing, switching PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA03288FCCMEinfo.pdf http://podcast.peerviewpress.com/PsychiatryVideo/PA03288FCCMEinfo.pdf Fri, 04 May 2007 16:41:30 -0400 Science no 00:00:00 Bipolar disorder, schizophrenia, aripiprazole, clozapine, olanzapine, quetiapine, risperidone, ziprasidone, weight gain, sedation, atypical antipsychotic, side effects, dosing, switching PeerView Press In this activity, psychiatric experts discuss obstacles to the successful treatment of depression, including the high rate of disease relapse and the potential for drug-drug interactions with antidepressant use. Specifically, the consensus-accepted drug-drug or drug-food interactions of hypertensive crisis and serotonin syndrome are discussed, and tactics for averting these and other antidepressant-associated effects are presented. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, psychiatric experts discuss obstacles to the successful treatment of depression, including the high rate of disease relapse and the potential for drug-drug interactions with antidepressant use. Specifically, the consensus-accepted drug-drug or drug-food interactions of hypertensive crisis and serotonin syndrome are discussed, and tactics for averting these and other antidepressant-associated effects are presented. http://podcast.peerviewpress.com/PsychiatryVideo/PA03784FCr295.m4v http://podcast.peerviewpress.com/PsychiatryVideo/PA03784FCr295.m4v Thu, 03 May 2007 09:56:38 -0400 Science & Medicine no 00:46:59 Antidepressant, Depression, Depression, refractory, Dopamine, Hypertensive crisis, Monoamine oxidase inhibitor (MAOI), Norepinephrine, P450 metabolism, Selective serotonin-reuptake inhibitor (SSRI), Selegiline, Selegiline, transdermal PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA03784FCCMEinfo.pdf http://podcast.peerviewpress.com/PsychiatryVideo/PA03784FCCMEinfo.pdf Thu, 03 May 2007 09:56:07 -0400 Science & Medicine no 00:00:00 Antidepressant, Depression, Depression, refractory, Dopamine, Hypertensive crisis, Monoamine oxidase inhibitor (MAOI), Norepinephrine, P450 metabolism, Selective serotonin-reuptake inhibitor (SSRI), Selegiline, Selegiline, transdermal PeerView Press In this CME activity, experts in the treatment of adult ADHD present recent data on efficacy and safety of current and emerging agents used in the treatment of this condition. Diagnosis of this condition is also discussed. Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of adult ADHD present recent data on efficacy and safety of current and emerging agents used in the treatment of this condition. Diagnosis of this condition is also discussed. http://podcast.peerviewpress.com/PsychiatryVideo/PA03681FCr282.m4v http://podcast.peerviewpress.com/PsychiatryVideo/PA03681FCr282.m4v Thu, 26 Apr 2007 11:09:03 -0400 Science & Medicine no 00:26:53 Adult ADHD, ADHD, DSM-IV, comorbidity, Utah Criteria, ADHD self-report scale (ASRS), mixed amphetamphetine salts, dexmethylphenidate, atomoxetine, antidepressants, psychoeducation, psychotherapy, SPD465, guanfacine, LDX PeerView Press Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PsychiatryVideo/PA03681FCCMEinfo.pdf http://podcast.peerviewpress.com/PsychiatryVideo/PA03681FCCMEinfo.pdf Thu, 26 Apr 2007 11:08:42 -0400 Science & Medicine no 00:00:00 Adult ADHD, ADHD, DSM-IV, comorbidity, Utah Criteria, ADHD self-report scale (ASRS), mixed amphetamphetine salts, dexmethylphenidate, atomoxetine, antidepressants, psychoeducation, psychotherapy, SPD465, guanfacine, LDX